Cesca Therapeutics appoints Denis Rhein to board
This article was originally published in Scrip
California-based Cesca Therapeutics, an autologous cell-based regenerative medicine company, has named Mr Denis Michael Rhein to its board of directors. Mr Rhein is the founder and director of EMR Vermögensverwaltung, an investment management company and the founder, principal shareholder and director of Illumisound, an alternative energy efficient commercial lighting company. He also has over 30 years of corporate banking and securities experience at Deutsche Bank in Frankfurt, Germany.
You may also be interested in...
The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.